Skye Bioscience, Inc. - SKYE

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$10.66M
QoQ value delta ($000)
-$1.486M (-12.24%)
Implied price effect (QoQ)
-17.04%
Shares
Total shares
17,156,814
QoQ shares delta
+939,224 (+5.79%)
Total shares held by funds (by quarter)

Market chart (SKYE)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 41 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
5AM Venture Management, LLC 5,950 9,681,763 1.65%
Versant Venture Management, LLC 1,233 2,007,704 0.87%
BAKER BROS. ADVISORS LP 968 1,575,243 0.01%
VANGUARD GROUP INC 662 882,785 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 470 764,457 0.0%
SPHERA FUNDS MANAGEMENT LTD. 417 678,928 0.07%
BlackRock, Inc. 175 286,131 0.0%
GEODE CAPITAL MANAGEMENT, LLC 170 277,256 0.0%
MILLENNIUM MANAGEMENT LLC 158 258,200 0.0%
PLATINUM INVESTMENT MANAGEMENT LTD 143 233,095 0.04%
VANGUARD FIDUCIARY TRUST CO 64 104,229 0.0%
CITADEL ADVISORS LLC 60 98,900 0.0%
STATE STREET CORP 46 75,326 0.0%
TWO SIGMA ADVISERS, LP 30 40,982 0.0%
UBS Group AG 28 45,762 0.0%
XTX Topco Ltd 25 40,919 0.0%
TWO SIGMA INVESTMENTS, LP 15 25,684 0.0%
NORTHERN TRUST CORP 12 20,142 0.0%
Engineers Gate Manager LP 12 20,194 0.0%
BARCLAYS PLC 11 18,089 0.0%
GROUP ONE TRADING LLC 6 11,205 0.0%
Vanguard Global Advisers, LLC 2 4,557 0.0%
MORGAN STANLEY 1 2,549 0.0%
JPMORGAN CHASE & CO 0 66 0.0%
HARBOUR INVESTMENTS, INC. 0 1 0.0%